These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Photodynamic therapy for choroidal neovascularization after thermal laser photocoagulation for diabetic macular edema. Shah GK. Am J Ophthalmol; 2003 Jan; 135(1):114-6. PubMed ID: 12504717 [Abstract] [Full Text] [Related]
3. Photodynamic therapy for iatrogenic CNV due to laser photocoagulation in central serous chorioretinopathy. Cakir M, Cekiç O, Yilmaz OF. Ophthalmic Surg Lasers Imaging; 2009 Jan; 40(4):405-8. PubMed ID: 19634747 [Abstract] [Full Text] [Related]
4. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Augustin AJ, Schmidt-Erfurth U. Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209 [Abstract] [Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [Abstract] [Full Text] [Related]
7. Atypical choroidal neovascularization in radiation retinopathy. Spaide RF, Borodoker N, Shah V. Am J Ophthalmol; 2002 May; 133(5):709-11. PubMed ID: 11992875 [Abstract] [Full Text] [Related]
8. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration. Hariprasad SM, Shah GK. Ophthalmic Surg Lasers Imaging; 2005 May; 36(3):258-60. PubMed ID: 15957487 [Abstract] [Full Text] [Related]
9. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980 [Abstract] [Full Text] [Related]
10. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC, Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216 [Abstract] [Full Text] [Related]
13. Treatment of subfoveal choroidal neovascularization secondary to choroidal nevus using photodynamic therapy. Levy J, Shneck M, Klemperer I, Lifshitz T. Ophthalmic Surg Lasers Imaging; 2005 Apr; 36(4):343-5. PubMed ID: 16156155 [Abstract] [Full Text] [Related]
17. Photodynamic therapy increases the eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degeneration. Piermarocchi S, Lo Giudice G, Sartore M, Friede F, Segato T, Pilotto E, Midena E. Am J Ophthalmol; 2002 Apr; 133(4):572-5. PubMed ID: 11931801 [Abstract] [Full Text] [Related]
18. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD, Lukas J, Olsen K, Potter M, Reaves A, Rosenfeld P, Schachat AP, Strong HA, Wenkstern A, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group, Verteporfin in Photodynamic Therapy Study Group. Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608 [Abstract] [Full Text] [Related]
19. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Farah ME, Costa RA, Muccioli C, Guia TA, Belfort R. Am J Ophthalmol; 2002 Jul; 134(1):137-9. PubMed ID: 12095828 [Abstract] [Full Text] [Related]